blog - Hemanext

Hemanext Continues European Rollout of Hemanext ONE® RBC Processing and Storage System

Groundbreaking technology to be deployed to transfuse thalassemia patients in Italy and acute bleeding burn patients in Norway LEXINGTON, Mass., May 25, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced...

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

News, Press Release, SCDAA

Partnership Will Expand to Include Educational and Donation Event with OneBlood LEXINGTON, Mass., January 17, 2023, – Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., a leading innovator in blood processing, storage, and transfusion...

Hemanext Announces Close of Series B Equity Funding Round

Hemanext, Press Release

Raises $18 Million in New Equity Financing Appoints Healthcare Luminary Dr. Ismail Kola to Board of Directors, Adding Clinical Development Expertise Progresses European Commercial Launch with Rollout to Key Distributors and Leading Hospitals and Blood Centers ...

European Patients Have Begun Receiving Transfusions with Hemanext ONE® RBC Processing and Storage System

Hemanext, Press Release

LEXINGTON, Mass., September 7, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced that it has initiated the rollout of its Hemanext ONE® RBC (Red Blood Cell) Processing and Storage System in...

Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances

Hemanext, Press Release

Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions.1 PRESS RELEASE – LEXINGTON, Mass., August 5, 2022 – (PR.com) – Hemanext Inc. Hypoxic storage preserves faster oxygen unloading from red blood...

Hemanext Launches European Sales of Hemanext ONE® System in Italy and the Nordics

Hemanext, Press Release

Hemanext signs agreements with leading European healthcare distributors to provide hospitals and clinicians with Hemanext ONE® system, marking the initiation of commercialization activities after CE Mark certification LEXINGTON, Mass., August 23, 2022, PR NEWSWIRE –...

Hemanext to Begin Rollout of Hemanext ONE® RBC Processing and Storage System in Europe

Hemanext, Press Release

LEXINGTON, Mass., July 12, 2022 – PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced a significant milestone in the rollout of its Hemanext ONE® RBC (Red Blood Cell) Processing and Storage...

Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa

Hemanext, Press Release

LEXINGTON, Mass., July 05, 2022 – (PR.com) – Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of...

Science Innovation Forum

Events, Hemanext, News

Science & Innovation Forum – The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. When: Thursday, May 5, 2022 4:00 – 5:00 PM (ET)...

Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation

AAMDS, Hemanext, Press Release

LEXINGTON, Mass., February 02, 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing, storage, and transfusion technology, is proud to announce a new partnership with The Aplastic Anemia & MDS International...

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE

Recent Posts